Veristat Case Studies

1. Accelerate Your Oncology Breakthroughs 4/16/2025

   Finding the right partnership can help your oncology clinical trials overcome trial complexities through strategic planning, a deep scientific understanding, and operational excellence.

2. Relieving The Strain Of Publishing During Regulatory Registration 8/7/2024

   Go inside how an expertly handled NDA submission for a biopharma company ensured timely FDA approval despite challenges.

3. Enhance DMC Services By Harnessing Biostatistics Expertise 8/7/2024

   Discover how expert biostatistics and project management ensured data integrity and efficient DMC operations in a complex clinical trial for hematologic cancer cell therapies.

4. Global Regulatory Excellence During The Clinical Development Lifecycle 5/8/2024

   Navigating the intricate global regulatory path is crucial for clinical development success. See how expert-backed support has consistently propelled sponsors toward regulatory excellence.

5. Pursuing Breakthrough Therapies For Rare Metabolic Diseases 2/14/2024

   Explore how a comprehensive clinical trial team expertly coordinated the dosing administration and data review for gene therapy, ensuring meticulous management and streamlined processes.

6. Strategic Clinical Consulting Success Stories 2/13/2024

   Explore real-world examples of how the combination of strategic consulting, regulatory insights, and technical expertise can impact the development and approval process.

7. Sponsor Overcomes Hold And Steers Products Through Development 11/2/2023

   Uncover how a small-sized biotech company was able to resolve critical regulatory CMC deficiencies to meet FDA requirements.

8. Medical Writing Support Relieves A Burdensome Review 11/2/2023

   Unearth how medical writing and project management teams were able to streamline the development and review of a critical marketing application document.

9. Proof-Of-Concept Study Enabled To Drive Novel Gene Therapy Program 9/29/2023

   Unearth how a natural history trial aimed at addressing the exceptionally rare neurological disease affecting pediatric patients with no existing treatment options was executed successfully.

10. A Comprehensive Planning Approach For Cancer Antibody 9/29/2023

    Discover how a clinical-stage biotech company was able to accelerate pathways for development and regulatory review of their first Phase 1 protocol for an immuno-oncology antibody.